# Metformin ER 750 mg Tablets, Fed

> **NCT00834613** · PHASE1 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Glucophage® XR 750 mg Tablets
- **DRUG:** Metformin ER 750 mg Tablets

## Key facts

- **NCT ID:** NCT00834613
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2003-08
- **Final completion:** 2003-08
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00834613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00834613, "Metformin ER 750 mg Tablets, Fed". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00834613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*